__________________________________________________________________

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C.  20549

                                    FORM 8-K

                                 CURRENT REPORT
                       Pursuant to Section 13 OR 15(d) of
                       The Securities Exchange Act of 1934

    Date of Report  (Date of Earliest Event Reported):    December 10, 2008


                        N-VIRO INTERNATIONAL CORPORATION
             (Exact Name of Registrant as Specified in its Charter)


     Delaware                         0-21802                   34-1741211
(State or Other Jurisdiction of  (Commission File Number)     (IRS Employer
Incorporation or Organization)                               Identification No.)


     3450 W. Central Avenue, Suite 328
     Toledo, Ohio                                             43606
  (Address of principal executive offices)                  (Zip Code)

      Registrant's telephone number, including area code:    (419) 535-6374

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))

       __________________________________________________________________




ITEM  1.01     ENTRY  INTO  A  MATERIAL  DEFINITIVE  AGREEMENT

     On  December  10,  2008,  N-Viro  International  Corporation issued a press
release  regarding  an  additional purchase order received from the Tohopekaliga
Water  Authority, Kissimmee, Florida, for the treatment of biosolids services to
be  provided  by the Company's wholly-owned subsidiaries, Florida N-Viro and Bio
Mineral  Transportation.  The  press  release is attached as Exhibit 99.1 and is
incorporated  by  reference  into  this  item.


ITEM 9.01 - FINANCIAL STATEMENTS AND EXHIBITS

(c)   Exhibits
          Exhibit No.     Description
          -----------     --------------------------------------
          99.1            Press Release dated December 10, 2008.

The information in this Form 8-K, and the exhibit hereto, is being furnished and
shall  not  be  deemed  "filed"  for  purposes  of  Section 18 of the Securities
Exchange  Act  of  1934,  as  amended,  nor  shall  it be deemed incorporated by
reference  in any filing under the Securities Act of 1933, as amended, except as
shall  be  expressly  set  forth  by  specific  reference  in  such  filing.

    SIGNATURE

     Pursuant to the requirements of the Securities Exchange Act of 1934, the
Company has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                        N-VIRO INTERNATIONAL CORPORATION

Dated:          December 10, 2008          By:     /s/  James K. McHugh
                -----------------                  --------------------
                                                   James K. McHugh
                                                   Chief Financial Officer